Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-24

Clinical Trial Update: Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation [NA]

View source ↗

Summary

This completed clinical trial compared macular pigment density in unilateral wet age-related macular degeneration versus non-AMD individuals, with or without lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein and zeaxanthin supplement (lutein; zeaxanthin)

Snippet

Sponsor: Affordance | Conditions: Exudative Age-related Macular Degeneration | NA | Status: COMPLETED